Evaluation of an Accelerated Body-whole Bone CT Procedure With the CZT "VERITON-CT ™" Camera
OSS
1 other identifier
interventional
146
0 countries
N/A
Brief Summary
The purpose of the OSS study is to evaluate a procedure involving a single full body TEMP / TDM 3D recording with a new semiconductor camera, the VERITON-CT ™ (Spectrum Dynamics Medical). This recording can be done in less than 25 minutes due to an original system of CZT (Cadmium-Zinc-Telluride) detectors allowing to increase the quality of the images and especially, to multiply by a factor 2 to 3 the detection sensitivity. This camera is also equipped with a scanner capable of obtaining a body-to-integer recording with a low level of irradiation (≤ 2 mSv)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2020
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 6, 2019
CompletedFirst Posted
Study publicly available on registry
November 8, 2019
CompletedStudy Start
First participant enrolled
January 20, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 21, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 20, 2022
CompletedNovember 8, 2019
November 1, 2019
1 year
November 6, 2019
November 6, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
concordance between the two procedures
Concordance between the 2 procedures of the importance of scintigraphic abnormalities evoking a neoplastic process and which will be classified into 3 categories (these categories may correspond to different medical and therapeutic care) : 1) absence of any suspicious focus, 2) 1 or 2 metastases 3) more than 2 metastases
half hour
Secondary Outcomes (1)
concordance between the two procedures 3D
half hour
Study Arms (2)
group 1 in pair week
OTHERIn pair week, patients will inclued in group1: the conventional recording followed by complementary images SPECT/CT, will be realized in first intention and the procedure of recording in camera VERITON will be recorderd in second intention
group 2 in odd week
OTHERin odd week, patients will inclued in group2: the procedure of recording of 25 minutes in camera VERITON-CT ™, will be realized in first intention and the procedure of conventional recording followed by complementary images SPECT/CT will be recorded in second intention
Interventions
The procedure of recording of 25 minutes in camera VERITON-CT ™ including the registration whole body 3D coupled to a scanner low dose (CT) will be added to conventional recording followed by complementary images SPECT/CT
Eligibility Criteria
You may qualify if:
- Patient having read and understood the information document and having signed the consent.
- Patient referred for bone scintigraphy to detect possible metastatic or primary neoplastic lesions (known neoplastic antecedent), or for assessment and / or follow-up of known neoplastic bone lesions
- Patient acceptant de réaliser les 25 minutes d'enregistrement supplémentaire avec la caméra VERITON-CT™.
- Patient being affiliated to a social security scheme
You may not qualify if:
- A woman who is pregnant or of childbearing age and without suitable contraceptive means
- No signature of the informed consent form by the patient.
- Unstable medical condition and / or inability to remain still in the supine position during the recordings
- Person with a known allergy to one of the components of the radiotracer (TECHNESCAN HDP).
- Person deprived of liberty by a judicial or administrative decision.
- Major person subject to a legal protection measure (guardianship, curatorship, safeguard of justice).
- Major person unable to express consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Central Hospital, Nancy, Francelead
- GIE NANCYCLOTEPcollaborator
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 6, 2019
First Posted
November 8, 2019
Study Start
January 20, 2020
Primary Completion
January 21, 2021
Study Completion
January 20, 2022
Last Updated
November 8, 2019
Record last verified: 2019-11
Data Sharing
- IPD Sharing
- Will not share